Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Rayont Inc. (RAYT)

Compare
0.0291
0.0000
(0.00%)
At close: April 8 at 4:00:00 PM EDT
Loading Chart for RAYT
  • Previous Close 0.0000
  • Open 0.1000
  • Bid --
  • Ask --
  • Day's Range 0.1000 - 0.1000
  • 52 Week Range 0.0291 - 0.1000
  • Volume 1
  • Avg. Volume 0
  • Market Cap (intraday) 1.46M
  • Beta (5Y Monthly) 4.85
  • PE Ratio (TTM) 1.46
  • EPS (TTM) 0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Rayont Inc., together with its subsidiaries, a healthcare company, engages in the manufacture and distribution of alternative medicine products and related services in the United States and internationally. Its products include health foods and nutraceuticals; functional food, supplements, and complementary and alternative medicine products; online naturopath consulting services; Tugun Compounding, a custom-made compounding pharmacy; skin DNA testing services; cosmetic range of products under the rosa naturals brand; and remedial massage and myotherapy. The company was formerly known as Velt International Group Inc. and changed its name to Rayont Inc. The company was founded in 2011 and is based in Palo Alto, California.

www.rayont.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: RAYT

View More

Performance Overview: RAYT

Trailing total returns as of 4/8/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RAYT
0.00%
S&P 500 (^GSPC)
15.28%

1-Year Return

RAYT
0.00%
S&P 500 (^GSPC)
4.22%

3-Year Return

RAYT
98.49%
S&P 500 (^GSPC)
11.02%

5-Year Return

RAYT
66.16%
S&P 500 (^GSPC)
81.19%

Compare To: RAYT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RAYT

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    41.58%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    21.10%

  • Revenue (ttm)

    1.16M

  • Net Income Avi to Common (ttm)

    482.6k

  • Diluted EPS (ttm)

    0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    72.86k

  • Total Debt/Equity (mrq)

    35.24%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: RAYT

View More

Company Insights: RAYT

Research Reports: RAYT

View More

People Also Watch